Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 26,000 | 160,000 | 28,000 | 26,000 | 48,000 |
| Gross Profit | 26,000 | 160,000 | 28,000 | 26,000 | 48,000 |
| Operating Expenses | 168,000 | 168,000 | 150,000 | 129,000 | 153,000 |
| Operating Income | -142,000 | -8,000 | -122,000 | -103,000 | -105,000 |
| Interest Expense | 3,000 | 2,000 | 1,000 | 2,000 | 1,000 |
| Other Income | 10,000 | 10,000 | 11,000 | 12,000 | 14,000 |
| Pre-tax Income | -135,000 | 0 | -112,000 | -93,000 | -92,000 |
| Net Income Continuous | -135,000 | N/A | -112,000 | -94,000 | -92,000 |
| Net Income | $-135,000 | $N/A | $-112,000 | $-94,000 | $-92,000 |
| EPS Basic Total Ops | -1.27 | N/A | -1.14 | -1.07 | -1.00 |
| EPS Basic Continuous Ops | -1.27 | N/A | -1.14 | -1.07 | -1.01 |
| EPS Diluted Total Ops | -1.27 | N/A | -1.14 | -1.07 | -1.00 |
| EPS Diluted Continuous Ops | -1.27 | N/A | -1.14 | -1.07 | -1.01 |
| EPS Diluted Before Non-Recurring Items | -1.27 | 0.00 | -1.14 | -1.03 | -1.00 |
| EBITDA(a) | $-143,000 | $-9,000 | $-123,000 | $-106,000 | $-109,000 |